GloMY is a national, multicentre, randomised controlled open-label pilot trial of Myfortic plus short course steroids versus standard care in patients with FSGS and IgAN. The aim of GloMY is to determine the feasibility of running a full-scale phase III randomised trial. It is managed by the BCTU at the University of Birmingham. http://www.birmingham.ac.uk/research/activity/mds/trials/bctu/trials/renal/glomy/news.aspx?MiniListing_SyndicationType=1 Contensis: http://www.contentmanagement.co.uk http://www.birmingham.ac.uk/research/impact/thebirminghambrief/items/23-05-13Are-credit-unions-failing-or-are-they-repositioning-themselves-for-the-future.aspx Thu, 23 May 2013 10:46:00 GMT http://www.birmingham.ac.uk/research/impact/thebirminghambrief/items/23-05-13Are-credit-unions-failing-or-are-they-repositioning-themselves-for-the-future.aspx http://www.birmingham.ac.uk/students/courses/postgraduate/taught/govsoc/modules/theories-of-global-cooperation.aspx Tue, 21 May 2013 16:41:00 GMT http://www.birmingham.ac.uk/students/courses/postgraduate/taught/govsoc/modules/theories-of-global-cooperation.aspx ICCS multimedia